Records 1 - 9
| Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study.
The Lancet. Respiratory medicine 2021 Mar .
Shi Yuankai, Hu Xingsheng, Zhang Shucai, Lv Dongqing, Wu Lin, Yu Qitao, Zhang Yiping, Liu Li, Wang Xiang, Cheng Ying, Ma Zhiyong, Niu Hongrui, Wang Dong, Feng Jifeng, Huang Cheng, Liu Chunling, Zhao Hui, Li Jingzhang, Zhang Xiaodong, Jiang Yong, Gu Chu
| Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2015 Jun 10 (6): 910-23.
Chen Nan, Fang Wenfeng, Zhan Jianhua, Hong Shaodong, Tang Yanna, Kang Shiyang, Zhang Yaxiong, He Xiaobo, Zhou Ting, Qin Tao, Huang Yan, Yi Xianping, Zhang
| The A Allele at rs13419896 of EPAS1 Is Associated with Enhanced Expression and Poor Prognosis for Non-Small Cell Lung Cancer.
PloS one 2015 10 (8): e0134496.
Putra Andika C, Eguchi Hidetaka, Lee Kian Leong, Yamane Yuko, Gustine Ewita, Isobe Takeshi, Nishiyama Masahiko, Hiyama Keiko, Poellinger Lorenz, Tanimoto Kei
| The protective role of polymorphism MKK4-1304 T>G in nasopharyngeal carcinoma is modulated by Epstein-Barr virus' infection status.
International journal of cancer. Journal international du cancer 2012 May 130 (9): 1981-90.
Zheng Jian, Liu Bin, Zhang Liyuan, Jiang Lan, Huang Binfang, You Yonghe, Jiang Qingping, Zhang Shuxu, Lu Jiachun, Zhou Yife
| Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction.
World journal of surgical oncology 2012 10 (1): 14.
Wang Wen-Ping, Wang Kang-Ning, Gao Qiang, Chen Long-
| Functional genetic variants of c-Jun and their interaction with smoking and drinking increase the susceptibility to lung cancer in southern and eastern Chinese.
International journal of cancer. Journal international du cancer 2011 Dec .
Huang B, Liu B, Yang L, Li Y, Cheng M, Huang D, Wang H, Zhang X, Zheng J, Li Q, Ji W, Zhou Y, Lu J
| C10ORF97 is a novel tumor-suppressor gene of non-small-cell lung cancer and a functional variant of this gene increases the risk of non-small-cell lung cancer.
Oncogene 2011 Sep 30 (39): 4107-17.
Shi Y, Chen J, Li Z, Zhang Z, Yu H, Sun K, Wang X, Song X, Wang Y, Zhen Y, Yang T, Lou K, Zhang Y, Zhang G, Hu Y, Ji J, Hui
| Relative abundance of EGFR mutations predicts benefit from gefitinib treatment for advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Aug 29 (24): 3316-21.
Zhou Qing, Zhang Xu-Chao, Chen Zhi-Hong, Yin Xiao-Lu, Yang Jin-Ji, Xu Chong-Rui, Yan Hong-Hong, Chen Hua-Jun, Su Jian, Zhong Wen-Zhao, Yang Xue-Ning, An She-Juan, Wang Bin-Chao, Huang Yi-Sheng, Wang Zhen, Wu Yi-Lo
| KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: a meta-analysis of 22 studies.
Lung cancer (Amsterdam, Netherlands) 2010 Sep 69 (3): 272-8.
Mao Chen, Qiu Li-Xin, Liao Ru-Yan, Du Fang-Bing, Ding Hong, Yang Wan-Chun, Li Jin, Chen Qi